September 2021 - Page 8 of 35

MondaySep 27, 2021 9:00 am

Sugarmade Inc. (SGMD) Closes on Property Acquisition, Will Use LA Spot as Nug Avenue Delivery Hub

Cannabis-delivery acquisitions increasing as companies want in on explosive growth of e-commerce cannabis sales CEO announces newly acquired property will serve as location of new SGMD Nug Avenue delivery hub Sugarmade signed MOU for licenses to serve as essential piece of plan to open three cannabis-related commercial operations in California Amid growing interest and acquisition activity in California’s direct-to-consumer cannabis delivery sector, Sugarmade (OTC: SGMD) has closed on its most recent acquisition, a parcel of prime property in Los Angeles, which it plans to use as a new distribution/delivery hub for its Nug Avenue cannabis delivery segment (https://ibn.fm/4jB0F). “The explosive…

FridaySep 24, 2021 2:08 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

FridaySep 24, 2021 1:54 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

FridaySep 24, 2021 1:39 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CDA Technology Detects Risk of Over 25 Different Cancer Types

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a recognized innovator and leader in the field of early cancer screening and detection. Its core product and proven revenue generator, the pioneering Cancer Differentiation Analysis (“CDA”) platform, offers novel capabilities by looking for signals to help it assess the risk of cancer occurring before a tumor has developed. This approach is unlike the blood sample-based cancer screenings, which generally target protein-based biomarkers, genomic signals, such as circulating tumor DNA (“ct-DNA”), circulating in the bloodstream to determine if a cancer exists and is spreading.…

FridaySep 24, 2021 1:28 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Garners Attention as ‘Emerging Leader in the Psychedelic Therapeutics Space’

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently released its Q1 2021 operational and financial report for the period ended June 30, 2021. The biotech company hit several milestones, including becoming the first psychedelic company to list on the NYSE American LLC stock exchange and raising more than CA$120 million. In addition, Cybin has started the next phase of its digital therapeutics platform, signed an exclusive R&D collaboration agreement with TMS NeuroHealth Centers Inc to establish Mental Health Centers of Excellence, as well as commenced scaling up its…

FridaySep 24, 2021 12:25 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Release FY 2021 Financial Report and Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has released its financial results and corporate update for FY 2021. In addition, the company announced a conference call and webcast, in which company leadership will discuss the report. Interested parties can access a replay of the webcast for 90 days. Corporate highlights of the report include the definitive agreement the company entered to acquire BayMedica Inc., a private company specializing in the manufacture and commercialization of rare cannabinoids; the announcement that INM’s IntegraSyn(TM) cannabinoid manufacturing approach had achieved a level of 2g/L cannabinoid yield,…

FridaySep 24, 2021 9:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Solution for Faster and More Effective Drug Delivery

One of the main challenges with drug delivery and the overall effectiveness of the drugs is first-pass metabolism/excretion Lexaria solves this problem with its DehydraTECH(TM) drug delivery technology Since the company began working on this technology back in 2014, it has made major strides in the delivery of hypertension and anti-viral treatments Since its inception, Lexaria Bioscience (NASDAQ: LEXX) has remained committed to enhancing the speed and overall efficiency of orally delivered fat-soluble active molecules in drugs. With its drug delivery technology, DehydraTECH(TM), the company has aided in developing hypertension and anti-viral treatments (https://ibn.fm/96k7t). This is a big achievement for…

FridaySep 24, 2021 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ideally Situated in Burgeoning Cannabis Beverage Sector

EMR report projects that North America is likely to be fastest, largest marketplace for cannabis beverages Cannabis beverage industry projected to grow at CAGR of 48% in the next five years, reaching an anticipated $12.7 billion by 2026 BevCanna manufactures its own beverage product lines, offers white-label services to companies looking for the highest-quality products available North America will be a leader in the global cannabis beverage market, according to a recent Expert Market Research (“EMR”) report (https://ibn.fm/ucsAZ). This projection bodes well for BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products…

FridaySep 24, 2021 9:30 am

Brain Scientific Inc. (BRSF) is Making EEGs Accessible to 5,900 US Hospitals

5,900 hospitals in the US lack the necessary extensive EEG tech BRSF has created a cost-effective solution capable of supplying these hospitals with the equipment needed and broadening the reach of each neurologist Emergency departments and hospitals are not the only markets in need of brain monitoring devices, and the industry is expected to grow to $208 billion by 2023 For most U.S. patients, an EEG is mostly unavailable during their journey, from home by EMS to the Emergency department. Additionally, for those patients who are admitted to the ICU, less than 45 percent of ICUs offer EEG monitoring. There…

FridaySep 24, 2021 9:15 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) and the Critical Need for Better Disease Diagnosis

Up to 70% of all medical decisions are based on lab tests. These tests cost between 3% and 6% of total patient-care costs The average patient spends about $260 on lab tests, a figure that is mainly associated with waiting for test results With point-of-care (“POC”) testing, waiting time can improve by as much as 46 minutes per patient, thus making it cheaper for the patient Avricore understands this problem, hence its investment in point-of-care technologies designed to make disease diagnosis easier, affordable, and more efficient Over the past few decades, disease diagnosis has proven to be the single most…

Site Search

Company Search

Month: September 2021

Sugarmade Inc. (SGMD) Closes on Property Acquisition, Will Use LA Spot as Nug Avenue Delivery Hub

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CDA Technology Detects Risk of Over 25 Different Cancer Types

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Garners Attention as ‘Emerging Leader in the Psychedelic Therapeutics Space’

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Release FY 2021 Financial Report and Corporate Update

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Solution for Faster and More Effective Drug Delivery

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ideally Situated in Burgeoning Cannabis Beverage Sector

Brain Scientific Inc. (BRSF) is Making EEGs Accessible to 5,900 US Hospitals

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) and the Critical Need for Better Disease Diagnosis

Market Basics

Newsletter Publishers

Public Companies